Transcranial Photobiomodulation
IN THIS LESSON: SAFETY AND TOLERABILITY
Across published randomized and open-label studies encompassing more than 5,000 tPBM sessions, no serious adverse events have been attributed to laser or light therapy.
In the acute moderate TBI trial, no adverse events were referable to LLLT.
Transcranial laser therapy has been administered safely in children as young as 2 years and in elderly adults.